ControlRad is a privately-held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures for patients and healthcare professionals. These products are designed to improve safety without compromising image quality or workflow. This is accomplished with an integrated set of proprietary components which optimize the X-ray beam to deliver optimal image quality in the clinically-relevant region of focus of the physician while maintaining appropriate resolution in the periphery. ControlRad is headquartered in Atlanta and has engineering development facilities in Kfar Saba, Israel. For more information, visit www.controlrad.com.
Location: United States, Georgia, Peachtree Corners
Employees: 11-50
Total raised: $15M
Founded date: 2011
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.10.2019 | Series B | $15M | - |
Mentions in press and media 9
| Date | Title | Description |
| 04.03.2021 | ControlRad® Announces FDA Clearance for ControlRad Select USA - English USA - English USA - English | |
| 30.11.2020 | ControlRad® Secures Silicon Valley Bank Senior Credit Facility | |
| 07.10.2019 | How ControlRad Will Reduce the Rates of Radiation Exposure for Physicians | When surgeons and nurses are operating on a patient, they shouldn't have to worry about being exposed to radiation from a fluoroscopic X-Ray. And that’s where Atlanta medtech startup ControlRad comes in. Last week, the company raised $15 mi... |
| 04.10.2019 | Daily funding roundup - October 3rd, 2019 | ReFirm Labs raised $2M; Verisart landed $2.5M; Diligent Robotics closed $3M ReFirm Labs: ReFirm Labs is a maker of IoT and firmware security software. ReFirm Labs has raised $2 million in funding co-led by DataTribe and New Dominion Angels,... |
| 02.10.2019 | Questa Capital Leads $15M Series B for ControlRad | ATLANTA--(BUSINESS WIRE)--ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), today announced it completed $15 millio... |
| 02.10.2019 | ControlRad Secures $15 Million Series B Financing | ATLANTA--(BUSINESS WIRE)--ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), today announced it completed $15 millio... |
| 02.10.2019 | ControlRad Secures $15M Series B | ATLANTA, GA, ControlRad has completed $15 million in financing led by Questa Capital. >> Click here for more funding data on ControlRad >> To export ControlRad funding data to PDF and Excel, click here ControlRad, Inc., a... |
| 02.10.2019 | ControlRad Raises $15M in Series B Financing | ControlRad, Inc., an Atlanta, GA-based medical technology company focused on reducing radiation exposure during fluoroscopically guided procedures (FGP), completed $15m in Series B financing. The round was led by Questa Capital. In addition... |
| 24.09.2019 | ControlRad touts first use for Trace radiation exposure reduction tech | ControlRad today said it completed the first clinical use of its Trace system. Atlanta-based ControlRad’s Trace technology can be integrated into mobile C-arms to help reduce radiation in fluoroscopically guided procedures. The company said... |